QuantumSi IncQSI
▲ PositiveCapitalrelevance
Beat Q2 estimates and reiterated 2026 guidance
Impact on stocks 1
Biotech & Genomic Medicine
QuantumSi IncQuantum-Si reported second-quarter 2026 results that beat analyst expectations. The company posted a GAAP loss of $0.11 per share, beating estimates by $0.01, while revenue of $0.34 million, down 42.4% year-over-year, exceeded forecasts by $0.04 million. Quantum-Si also reiterated its full-year 2026 guidance, which calls for revenue of approximately $1.0 million, adjusted total operating expenses of $98.0 million or less, and total cash usage of $93.0 million or less.
QuantumSi IncBeat Q2 estimates and reiterated 2026 guidance